U.S. federal trademark · Serial No. 79392943 · Reg. No. 7592796
Scientific research and development of preparations, agents and technology for the development of antibody therapeutics all for the treatment, and prophylaxis of human diseases, disorders and conditions, namely, cancer, autoimmune and inflammatory diseases; providing scientific information to scientists, physicians and health care providers in the field of cancer, autoimmune diseases, inflammatory diseases, and infectious diseases
Licensing of intellectual property
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.